Delivering better treatments
Camurus is committed to improving the lives of patients
with severe and chronic diseases
Disease areas
Focus on severe and chronic diseases
Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care
Events
Upcoming events
-
07 Nov
Interim Report January-September 2024
The interim report January-September is published on 7 November, 2024.
-
07 Nov
Interim Report January-September 2024 – Audiocast
Financial analysts and media are invited to attend a telephone conference and presentation of the second quarter results at 2.00 pm CET. Audiocast
-
19 Nov
SEB Healthcare Seminar
Camurus' President & CEO Fredrik Tiberg is presenting at this conference in Stockholm, 19 Novemer. The presentation can be seen by the conference participants. More information will follow closer to the event.
Latest financial report
Camurus’ Interim Report Second Quarter 2024
16 July 2024
Pipeline
Diversified pipeline with large potential
Camurus’ innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery.
sustainability
Sustainable solutions for a healthier world
Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders.
